NATCO PHARMA (CANADA) INC (E60PH-22DRUG/007/PH~000)
Contract number E60PH-22DRUG/007/PH
Contract award date
Expiry date
Amendment value CAD 49,904.00
Contract details
This contract was awarded to:
NATCO PHARMA (CANADA) INC.
- Business address
-
2000 ARGENTIA RD
PLAZA 1, SUITE 200MISSISSAUGA, Ontario, L5N1P7Canada -
Standardized name
-
NATCO PHARMA (CANADA) INC
- Procurement method
- Competitive – Open Bidding
-
Number of employees
-
10 to 19 employees
- Language(s)
-
English,French
- Selection criteria
- Lowest Price
Contract duration
Refer to the description above for full details.
Total value of contract
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.
CAD 68,556.62
Commodity - GSIN
- N6505 - Drugs and Biologicals
Contact information
Contracting organization
- Organization
-
Public Works and Government Services Canada
Buying organization(s)
Related notices
Amendments made to this contract (1) A total of 1 amendments have been made to this contract. Click to collapse
This is a list of the amendments made to contract
E60PH-22DRUG/007/PH that is awarded to NATCO PHARMA (CANADA) INC..
Amendment number
|
Contract value
|
Award date
|
|---|---|---|
| 001 | CAD 68 556.62 | 2022/09/09 |
Tender notices (1) This contract has 1 related tender notices. Click to collapse
|
Title
|
Solicitation Number
|
Publication date
|
Closing date
|
|---|---|---|---|
| Multi-Source Pharmaceuticals | E60PH-22DRUG/A | 2022/07/26 | 2022/08/15 |
Contracts awarded (13) This contract has 13 related award notices. Click to collapse
This is a list of other contracts that were awarded related to solicitation number E60PH-22DRUG/A. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment date
|
Award date
|
More details |
|---|---|---|---|---|
| Bauschhealth, Canada Inc | E60PH-22DRUG/003/PH | 2023/11/30 | 2022/09/13 | Viewthe details of contract E60PH-22DRUG/003/PH for Bauschhealth, Canada Inc |
| JAMP Pharma Corporation | E60PH-22DRUG/005/PH | 2023/06/01 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/005/PH for JAMP Pharma Corporation |
| Auro Pharma Inc | E60PH-22DRUG/002/PH | 2023/06/09 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/002/PH for Auro Pharma Inc |
| Hikma Canada Limited | E60PH-22DRUG/004/PH | 2023/06/05 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/004/PH for Hikma Canada Limited |
| Viatris | E60PH-22DRUG/013/PH | 2023/07/06 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/013/PH for Viatris |
| Omega Laboratories Limited | E60PH-22DRUG/009/PH | 2023/05/31 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/009/PH for Omega Laboratories Limited |
| Natco Pharma (Canada) Inc. | E60PH-22DRUG/007/PH | 2023/06/01 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/007/PH for Natco Pharma (Canada) Inc. |
| Pharmascience Inc. | E60PH-22DRUG/010/PH | 2023/05/31 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/010/PH for Pharmascience Inc. |
| SANDOZ CANADA INC. | E60PH-22DRUG/011/PH | 2023/06/09 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/011/PH for SANDOZ CANADA INC. |
| Odan Laboratories Ltd. | E60PH-22DRUG/008/PH | 2023/06/01 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/008/PH for Odan Laboratories Ltd. |
Contract history (28) This contract has 28 related contracts. Click to collapse
This is a list of other contracts that were awarded and their amendments. Click the link under “More details” to view the contract details.
